en POLSKI
eISSN: 2084-9834
ISSN: 0034-6233
Reumatologia/Rheumatology
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank


 
1/2010
vol. 48
 
Share:
Share:
more
 
 
abstract:
Editorial

Pathogenetic aspects of rheumatoid arthritis in terms therapeutic consequences

Stefan H. Mackiewicz

Reumatologia 2010; 48, 1: 1-3
Online publish date: 2010/04/09
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Rheumatoid arthritis (RA) presents an extremely complex disease which is manifested in a number of autoimmune phenomena. Susceptibility genes (DR-β) and environmental factors play an important role as initiating agents. The early stage of the disease involves activation of the immune system via TCR complex. Stimulated T and B lymphocytes express upregulation of genes, followed by high cytokine production and intensive signal transduction. The same mechanism operates in other cells (macrophages, fibroblasts, endothelial cells).
In consequence regulatory abnormalities present some kind of “biological unformed state”. The therapy is directed towards pleiotropic (modification) or selective (target) methods. In the former (pre-biological treatment) MTX alone or in combination with other modifiers and low doses of prednisone are in general use. In case of unresponsiveness anti-TNF-α; or other biologicals are recommended.
keywords:

Immunological stimulation, cells and molecules, pharmacological control







Quick links
© 2022 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.